Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathologic Characteristics and Mucin Expression in Brunner’s Gland Proliferating Lesions

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Brunner’s gland proliferating lesions, termed Brunner’s gland hamartoma, hyperplasia, or adenoma, is regarded as a benign condition. However, cancerous changes have been reported in Brunner’s gland proliferating lesions.

Aims

The purpose of this study was to define the characteristic features of Brunner’s gland proliferating lesions and evaluate any observed cancerous changes.

Methods

We analysed clinicopathologic features and mucin expression in 25 Brunner’s gland proliferating lesions.

Results

Brunner’s gland proliferating lesions were categorized as Brunner’s gland hamartoma or hyperplasia according to their tissue components. Brunner’s gland hamartoma commonly occurred in the duodenal bulb and exhibited a polypoid appearance, while Brunner’s gland hyperplasia was primarily observed in the second portion of duodenum as a submucosal mass and was accompanied by symptoms more frequently than Brunner’s gland hamartoma. The Brunner’s glands in Brunner’s gland proliferating lesions exhibited various morphologic characteristics, from normal-appearing glands to sclerotic glandular foci with atypia. Changes in MUC5 expression observed in both sclerotic glandular foci and dilated Brunner’s glands suggest that they might share a common mechanism and are associated with gastric foveolar metaplasia.

Conclusions

These findings indicate that most Brunner’s gland proliferating lesions are either hamartoma or hyperplasia, and that true neoplastic Brunner’s gland proliferating lesions are very rare. Thus, Brunner’s gland adenomas or carcinomas arising in Brunner’s gland proliferating lesions should be confirmed by ancillary tests, including immunostaining or molecular analysis, in addition to morphological criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mills SE. Histology for Pathologists. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.

    Google Scholar 

  2. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Isaacson PG. Gastrointestinal Pathology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  3. Botsford TW, Crowe P, Crocker DW. Tumors of the small intestine. A review of experience with 115 cases including a report of a rare case of malignant hemangio-endothelioma. Am J Surg. 1962;103:358–365.

    Article  CAS  PubMed  Google Scholar 

  4. Osborne R, Toffler R, Lowman RM. Brunner’s gland adenoma of the duodenum. Am J Dig Dis. 1973;18:689–694.

    Article  CAS  PubMed  Google Scholar 

  5. Levine JA, Burgart LJ, Batts KP, Wang KK. Brunner’s gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol. 1995;90:290–294.

    CAS  PubMed  Google Scholar 

  6. Chen YY, Su WW, Soon MS, Yen HH. Hemoclip-assisted polypectomy of large duodenal Brunner’s gland hamartoma. Dig Dis Sci. 2006;51:1670–1672.

    Article  PubMed  Google Scholar 

  7. Ohba R, Otaka M, Jin M, et al. Large Brunner’s gland hyperplasia treated with modified endoscopic submucosal dissection. Dig Dis Sci. 2007;52:170–172.

    Article  PubMed  Google Scholar 

  8. Akino K, Kondo Y, Ueno A, et al. Carcinoma of duodenum arising from Brunner’s gland. J Gastroenterol. 2002;37:293–296.

    Article  PubMed  Google Scholar 

  9. Itsuno M, Makiyama K, Omagari K, et al. Carcinoma of duodenal bulb arising from the Brunner’s gland. Gastroenterol Jpn. 1993;28:118–125.

    Article  CAS  PubMed  Google Scholar 

  10. Kushima R, Stolte M, Dirks K, et al. Gastric-type adenocarcinoma of the duodenal second portion histogenetically associated with hyperplasia and gastric-foveolar metaplasia of Brunner’s glands. Virchows Arch. 2002;440:655–659.

    Article  PubMed  Google Scholar 

  11. Shimizu N, Tanaka S, Morikawa J, et al. Early duodenal cancer of the bulb—report of a case. Gan No Rinsho. 1989;35:100–106.

    CAS  PubMed  Google Scholar 

  12. Suzuki T, Ito A, Takayasu H, et al. A case of duodenal Brunner’s gland hyperplasia associated with in situ carcinoma. Nippon Shokakibyo Gakkai Zasshi. 1995;92:1189–1193.

    CAS  PubMed  Google Scholar 

  13. Patel ND, Levy AD, Mehrotra AK, Sobin LH. Brunner’s gland hyperplasia and hamartoma: imaging features with clinicopathologic correlation. AJR Am J Roentgenol. 2006;187:715–722.

    Article  PubMed  Google Scholar 

  14. Giorgadze TA, Peterman H, Baloch ZW, et al. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation. Cancer. 2006;108:186–197.

    Article  PubMed  Google Scholar 

  15. Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995;55:2681–2690.

    CAS  PubMed  Google Scholar 

  16. Tamada S, Goto M, Nomoto M, et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int. 2002;52:713–723.

    Article  PubMed  Google Scholar 

  17. Ando H, Aihara R, Ohno T, Ogata K, Mochiki E, Kuwano H. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma. Br J Surg. 2009;96:901–909.

    Article  CAS  PubMed  Google Scholar 

  18. Baldus SE, Monig SP, Huxel S, et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res. 2004;10:2790–2796.

    Article  CAS  PubMed  Google Scholar 

  19. Park SY, Roh SJ, Kim YN, et al. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep. 2009;22:649–657.

    Article  CAS  PubMed  Google Scholar 

  20. Brookes MJ, Manjunatha S, Allen CA, Cox M. Malignant potential in a Brunner’s gland hamartoma. Postgrad Med J. 2003;79:416–417.

    Article  CAS  PubMed  Google Scholar 

  21. Faller G, Kirchner T. Low-grade intraepithelial neoplasia of Brunner’s gland. Histopathology. 2005;47:118–119.

    Article  CAS  PubMed  Google Scholar 

  22. Fujimaki E, Nakamura S, Sugai T, Takeda Y. Brunner’s gland adenoma with a focus of p53-positive atypical glands. J Gastroenterol. 2000;35:155–158.

    Article  CAS  PubMed  Google Scholar 

  23. Sakurai T, Sakashita H, Honjo G, Kasyu I, Manabe T. Gastric foveolar metaplasia with dysplastic changes in Brunner gland hyperplasia: possible precursor lesions for Brunner gland adenocarcinoma. Am J Surg Pathol. 2005;29:1442–1448.

    Article  PubMed  Google Scholar 

  24. Zanetti G, Casadei G. Brunner’s gland hamartoma with incipient ductal malignancy. Report of a case. Tumori. 1981;67:75–78.

    CAS  PubMed  Google Scholar 

  25. Fisher JK. Mucocele of a Brunner gland. Radiology. 1980;136:320.

    CAS  PubMed  Google Scholar 

  26. Golan J, Dollberg L, Dollberg M, Farkash T, Rivkin L. Cystic hamartoma of Brunner’s glands. Int Surg. 1978;63:173–175.

    CAS  PubMed  Google Scholar 

  27. Powers M, Sayuk GS, Wang HL. Brunner gland cyst: report of three cases. Int J Clin Exp Pathol. 2008;1:536–538.

    PubMed  Google Scholar 

  28. Taura M, Taura S, Kummerow FA, Noritomi S, Iwanaga S. An ultrastructural study of the Brunner’s cyst. Gastroenterol Jpn. 1977;12:241–244.

    CAS  PubMed  Google Scholar 

  29. Wolk DP, Knapper WH, Farr GH. Brunner’s gland cystadenoma of the duodenum. Am J Surg. 1973;126:439–440.

    Article  CAS  PubMed  Google Scholar 

  30. Chang MS, Kim WH, Kim YI. Brunner’s gland hamartoma. A clinicopathologic analysis of six cases. Korean J Gastrointest Endosc. 1994;14:19–23.

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 110-746, Korea

    Kyungeun Kim

  2. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea

    Se Jin Jang & Eunsil Yu

  3. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 138-736, Korea

    Ho June Song

Authors
  1. Kyungeun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Se Jin Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ho June Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eunsil Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eunsil Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K., Jang, S.J., Song, H.J. et al. Clinicopathologic Characteristics and Mucin Expression in Brunner’s Gland Proliferating Lesions. Dig Dis Sci 58, 194–201 (2013). https://doi.org/10.1007/s10620-012-2320-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2320-3

Keywords

Search

Navigation